| Metal complexes in cancer therapy–an update from drug design perspective U Ndagi, N Mhlongo, ME Soliman Drug design, development and therapy, 599-616, 2017 | 923 | 2017 |
| Theory and applications of covalent docking in drug discovery: merits and pitfalls HM Kumalo, S Bhakat, MES Soliman Molecules 20 (2), 1984-2000, 2015 | 175 | 2015 |
| Recent advancements in the development of anti-tuberculosis drugs S Chetty, M Ramesh, A Singh-Pillay, MES Soliman Bioorganic & medicinal chemistry letters 27 (3), 370-386, 2017 | 151 | 2017 |
| Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity B Honarparvar, T Govender, GEM Maguire, MES Soliman, HG Kruger Chemical reviews 114 (1), 493-537, 2014 | 134 | 2014 |
| Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid–polymer hybrid nanoparticles: In vitro and in silico studies N Seedat, RS Kalhapure, C Mocktar, S Vepuri, M Jadhav, M Soliman, ... Materials Science and Engineering: C 61, 616-630, 2016 | 81 | 2016 |
| Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery P Ramharack, MES Soliman Journal of Biomolecular Structure and Dynamics 36 (5), 1118-1133, 2018 | 80 | 2018 |
| Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ... International journal of biological macromolecules 91, 680-695, 2016 | 77 | 2016 |
| Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies SJ Sonawane, RS Kalhapure, S Rambharose, C Mocktar, SB Vepuri, ... International journal of pharmaceutics 504 (1-2), 1-10, 2016 | 75 | 2016 |
| Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies GM El-Zaafarany, ME Soliman, S Mansour, GAS Awad International journal of pharmaceutics 503 (1-2), 127-140, 2016 | 73 | 2016 |
| Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say? C Agoni, FA Olotu, P Ramharack, ME Soliman Journal of molecular modeling 26, 1-11, 2020 | 70 | 2020 |
| Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using … M Lawal, FA Olotu, MES Soliman Computers in Biology and Medicine 98, 168-177, 2018 | 64 | 2018 |
| In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2 M Rudrapal, AR Issahaku, C Agoni, AR Bendale, A Nagar, MES Soliman, ... Journal of Biomolecular Structure and Dynamics 40 (20), 10437-10453, 2022 | 62 | 2022 |
| Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design U Ndagi, AA Falaki, M Abdullahi, MM Lawal, ME Soliman RSC advances 10 (31), 18451-18468, 2020 | 60 | 2020 |
| An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase … S Bhakat, AJM Martin, MES Soliman Molecular BioSystems 10 (8), 2215-2228, 2014 | 59 | 2014 |
| Covalent versus non-covalent enzyme inhibition: which route should we take? A justification of the good and bad from molecular modelling perspective A Aljoundi, I Bjij, A El Rashedy, MES Soliman The protein journal 39 (2), 97-105, 2020 | 57 | 2020 |
| The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design U Ndagi, NN Mhlongo, ME Soliman Molecular BioSystems 13 (6), 1157-1171, 2017 | 56 | 2017 |
| Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones VN Badavath, S Ciftci-Yabanoglu, S Bhakat, AK Timiri, BN Sinha, G Ucar, ... Bioorganic chemistry 58, 72-80, 2015 | 56 | 2015 |
| A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses S Bhakat, W Karubiu, V Jayaprakash, MES Soliman European journal of medicinal chemistry 87, 677-702, 2014 | 55 | 2014 |
| Can we rely on computational predictions to correctly identify ligand binding sites on novel protein drug targets? Assessment of binding site prediction methods and a protocol … NK Broomhead, ME Soliman Cell biochemistry and biophysics 75, 15-23, 2017 | 54 | 2017 |
| Quantum mechanics implementation in drug-design workflows: does it really help? OA Arodola, MES Soliman Drug design, development and therapy, 2551-2564, 2017 | 52 | 2017 |
